Sleep Disorders Trial, Recruiting NCT06861998 Sponsor: Yan Fuxia Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06861998
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 0 to 3 years old
  • Children who are scheduled to have planned (non-emergency) surgery to correct a heart condition they were born with, where a heart-lung bypass machine will be used during the operation
  • Children who have been identified as having sleep problems based on a standard sleep screening questionnaire called the BISQ-R SF

Who may not be able to join:

  • Children who have already received any treatment for sleep problems before the surgery
  • Children whose heart surgery is considered higher risk, based on a medical complexity scoring system called RACHS-1, with a score of 4 or above (confirm with trial site)
  • Children who have a history of reduced blood or oxygen supply to the brain before surgery, or who have a developmental condition such as autism spectrum disorder
  • Children who have certain other serious health conditions before surgery, including those requiring breathing machine support, a history of requiring emergency resuscitation, severe liver or kidney problems, or other birth defects outside of the heart
  • Children who are already taking part in another clinical trial
  • Children whose family declines to sign the consent forms, or where the child is unlikely to be able to cooperate with the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fuxia Yan, Chinese Academy of Medical Sciences, Fuwai Hospital

Phone: 010-88396628

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Yan Fuxia
Registry
ClinicalTrials.gov
Start date
30 April 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of postoperative delirium

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov